IL253579A0 - Anti-light chain substituent antibodies - Google Patents
Anti-light chain substituent antibodiesInfo
- Publication number
- IL253579A0 IL253579A0 IL253579A IL25357917A IL253579A0 IL 253579 A0 IL253579 A0 IL 253579A0 IL 253579 A IL253579 A IL 253579A IL 25357917 A IL25357917 A IL 25357917A IL 253579 A0 IL253579 A0 IL 253579A0
- Authority
- IL
- Israel
- Prior art keywords
- light chain
- chain antibodies
- surrogate light
- surrogate
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562111018P | 2015-02-02 | 2015-02-02 | |
| PCT/US2016/015166 WO2016126488A1 (en) | 2015-02-02 | 2016-01-27 | Anti-surrogate light chain antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL253579A0 true IL253579A0 (en) | 2017-09-28 |
Family
ID=56564528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL253579A IL253579A0 (en) | 2015-02-02 | 2017-07-19 | Anti-light chain substituent antibodies |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10858448B2 (enExample) |
| EP (2) | EP3253793A4 (enExample) |
| JP (1) | JP2018507254A (enExample) |
| KR (1) | KR102590740B1 (enExample) |
| CN (1) | CN107849123A (enExample) |
| AU (1) | AU2016215676B2 (enExample) |
| CA (2) | CA2975346A1 (enExample) |
| HK (1) | HK1247941A1 (enExample) |
| IL (1) | IL253579A0 (enExample) |
| WO (1) | WO2016126488A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016126488A1 (en) | 2015-02-02 | 2016-08-11 | Sea Lane Biotechnologies, Llc | Anti-surrogate light chain antibodies |
| WO2016127043A1 (en) | 2015-02-05 | 2016-08-11 | Stc.Unm | Anti-pre-bcr antagonists and methods |
| AU2017366739B2 (en) | 2016-12-02 | 2023-11-23 | Angeles Therapeutics, Inc. | Synthetic immune receptors and methods of use thereof |
| US11407828B2 (en) * | 2019-02-01 | 2022-08-09 | Novarock Biotherapeutics, Ltd. | Anti-CLauDiN 18 antibodies and methods of use thereof |
| CA3138550A1 (en) * | 2019-04-30 | 2020-11-05 | Target Discovery Merger Sub II, LLC | Cancer associated antibody compositions and methods of use |
| CN112300282A (zh) * | 2020-11-03 | 2021-02-02 | 南京北恒生物科技有限公司 | 靶向cd7的人源化抗体及其用途 |
| IL305188A (en) * | 2021-02-16 | 2023-10-01 | Childrens Health Care D/B/A Childrens Minnesota | Methods for treating B-ALL by administering a pre-BCR complex antagonist |
| JP2025534161A (ja) * | 2022-10-04 | 2025-10-14 | ミンク セラピューティクス， インコーポレイテッド | 線維芽細胞活性化タンパク質（ｆａｐ）ｃａｒインバリアントナチュラルキラーｔ細胞及びその使用 |
| WO2025212740A1 (en) * | 2024-04-03 | 2025-10-09 | Mink Therapeutics, Inc. | Composition and methods for treating colorectal cancer liver metastasis (crc liver mets) |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2010A (en) | 1841-03-18 | Machine foe | ||
| US62950A (en) | 1867-03-19 | Improvement in apparatus foe the manufacture of vinegar | ||
| JPS60222842A (ja) | 1984-04-19 | 1985-11-07 | Fuji Photo Film Co Ltd | ハロゲン化銀写真乳剤およびその製造方法 |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5182205A (en) | 1986-11-27 | 1993-01-26 | Hoffmann-La Roche Inc. | Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor |
| DE3789138T2 (de) | 1986-11-27 | 1994-05-26 | Hoffmann La Roche | Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck. |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| WO1992018619A1 (en) | 1991-04-10 | 1992-10-29 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| US5871907A (en) | 1991-05-15 | 1999-02-16 | Medical Research Council | Methods for producing members of specific binding pairs |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| ES2341666T3 (es) | 1991-12-02 | 2010-06-24 | Medimmune Limited | Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos. |
| US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US7067284B1 (en) | 1992-01-27 | 2006-06-27 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US5233409A (en) | 1992-02-25 | 1993-08-03 | Schwab Karl W | Color analysis of organic constituents in sedimentary rocks for thermal maturity |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| GB9225453D0 (en) | 1992-12-04 | 1993-01-27 | Medical Res Council | Binding proteins |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| US6326155B1 (en) | 1995-03-20 | 2001-12-04 | Dyax Corp. | Engineering affinity ligands for macromolecules |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| US6706484B1 (en) | 1995-08-18 | 2004-03-16 | Morphosys Ag | Protein/(poly)peptide libraries |
| JP2978435B2 (ja) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | アクリロキシプロピルシランの製造方法 |
| GB9712818D0 (en) | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
| WO1999006541A1 (fr) * | 1997-07-29 | 1999-02-11 | Sumitomo Electric Industries, Ltd. | Anticorps du recepteur des cellules pre-b non humaines |
| JPH11133028A (ja) * | 1997-10-29 | 1999-05-21 | Sumitomo Electric Ind Ltd | 抗ヒトプレｂ細胞レセプター抗体 |
| US20030215453A1 (en) * | 2002-05-14 | 2003-11-20 | Dedera Douglas A. | Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein |
| GB2377997A (en) * | 2001-07-24 | 2003-01-29 | Bookham Technology Plc | Connection of a non-perpendicular optical fibre to an optical device |
| JP4602614B2 (ja) | 2001-09-26 | 2010-12-22 | アイシン精機株式会社 | 自動車用ドア |
| ATE536376T1 (de) * | 2003-12-23 | 2011-12-15 | Crucell Holland Bv | Humanes bindungsmolekül gegen cd1a |
| AU2007303572A1 (en) | 2006-10-02 | 2008-04-10 | Sea Lane Biotechnologies, Llc | Design and construction of diverse synthetic peptide and polypeptide libraries |
| JP5779350B2 (ja) | 2007-03-27 | 2015-09-16 | シー レーン バイオテクノロジーズ， エルエルシー | 抗体代替軽鎖配列を含む構築物およびライブラリー |
| CN102149727A (zh) | 2008-07-11 | 2011-08-10 | 航道生物技术有限责任公司 | 包含抗体替代卡帕轻链序列的构建体和文库 |
| EP3205723A1 (en) * | 2009-06-26 | 2017-08-16 | i2 Pharmaceuticals, Inc. | Expression of surrogate light chains |
| IL269565B2 (en) * | 2011-01-06 | 2024-06-01 | Dyax Corp | Plasma kallikrein binding proteins |
| WO2016126488A1 (en) | 2015-02-02 | 2016-08-11 | Sea Lane Biotechnologies, Llc | Anti-surrogate light chain antibodies |
| WO2016127043A1 (en) * | 2015-02-05 | 2016-08-11 | Stc.Unm | Anti-pre-bcr antagonists and methods |
-
2016
- 2016-01-27 WO PCT/US2016/015166 patent/WO2016126488A1/en not_active Ceased
- 2016-01-27 CA CA2975346A patent/CA2975346A1/en active Pending
- 2016-01-27 AU AU2016215676A patent/AU2016215676B2/en active Active
- 2016-01-27 EP EP16747000.4A patent/EP3253793A4/en not_active Withdrawn
- 2016-01-27 KR KR1020177024616A patent/KR102590740B1/ko active Active
- 2016-01-27 US US15/548,274 patent/US10858448B2/en active Active
- 2016-01-27 JP JP2017558627A patent/JP2018507254A/ja active Pending
- 2016-01-27 CN CN201680019431.XA patent/CN107849123A/zh active Pending
- 2016-01-27 HK HK18107353.6A patent/HK1247941A1/zh unknown
- 2016-01-27 EP EP22202435.8A patent/EP4177267A1/en active Pending
- 2016-01-27 CA CA3185253A patent/CA3185253A1/en active Pending
-
2017
- 2017-07-19 IL IL253579A patent/IL253579A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10858448B2 (en) | 2020-12-08 |
| KR20170120120A (ko) | 2017-10-30 |
| CA3185253A1 (en) | 2016-08-11 |
| EP3253793A1 (en) | 2017-12-13 |
| WO2016126488A1 (en) | 2016-08-11 |
| AU2016215676A1 (en) | 2017-08-10 |
| AU2016215676B2 (en) | 2021-12-02 |
| KR102590740B1 (ko) | 2023-10-18 |
| CN107849123A (zh) | 2018-03-27 |
| EP4177267A1 (en) | 2023-05-10 |
| US20180265594A1 (en) | 2018-09-20 |
| CA2975346A1 (en) | 2016-08-11 |
| EP3253793A4 (en) | 2018-11-14 |
| JP2018507254A (ja) | 2018-03-15 |
| HK1247941A1 (zh) | 2018-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3328894T3 (pl) | Przeciwciała dla il2rbeta/wspólnego łańcucha gamma | |
| GB2536082B (en) | Light bulb | |
| IL253579A0 (en) | Anti-light chain substituent antibodies | |
| GB201508180D0 (en) | Antibodies | |
| AU367755S (en) | Light | |
| PL3504233T3 (pl) | Wielospecyficzne przeciwciała ułatwiające selektywne parowanie łańcuchów lekkich | |
| GB201521985D0 (en) | Light fitting | |
| AU364013S (en) | Light bulb | |
| GB201509907D0 (en) | Antibodies | |
| PL2960545T3 (pl) | Łańcuch popychający ze sztywnym grzbietem | |
| SG10201912682XA (en) | Albumin-sugar chain complex | |
| GB201503438D0 (en) | Antibodies | |
| AU201711924S (en) | Light | |
| AU201711920S (en) | Light | |
| AU201711927S (en) | Light | |
| AU201711925S (en) | Light | |
| AU201711922S (en) | Light | |
| AU201711919S (en) | Light | |
| AU201615239S (en) | Light | |
| AU201615240S (en) | Light | |
| AU201711385S (en) | Light | |
| AU201711383S (en) | Light | |
| AU201711381S (en) | Light | |
| AU201711382S (en) | Light | |
| AU201711384S (en) | Light |